First real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (D4194R00005)

  • Markman, Ben (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)

Project: Research

AcronymPACIFIC-Real World
StatusActive
Effective start/end date17/10/1931/12/24

Keywords

  • Medical Oncology